Sentynl Therapeutics and BridgeBio Pharma announce asset purchase agreement for Nulibry EP News Bureau Mar 9, 2022 Under the terms of the agreement, Sentynl will acquire global rights to Nulibry, and will be responsible for its ongoing…
Zydus receives DCGI approval for Oxemia to treat anaemia in CKD patients EP News Bureau Mar 7, 2022 OxemiaTM (Desidustat) is an oral tablet formulation which is the first-in-India alternative to injectable…
Cadila Healthcare renamed as Zydus Lifesciences EP News Bureau Feb 25, 2022 Zydus unveils its ‘innovation and care’-centric corporate brand identity
